par Body, Jean-Jacques
Référence Expert review of anticancer therapy, 12, 3, page (307-322)
Publication Publié, 2012-03
Article révisé par les pairs
Titre:
  • Denosumab for the management of bone disease in patients with solid tumors.
Auteur:Body, Jean-Jacques
Informations sur la publication:Expert review of anticancer therapy, 12, 3, page (307-322)
Statut de publication:Publié, 2012-03
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:bone metastases
denosumab
skeletal-related events
supportive care
zoledronic acid
MeSH keywords:Antibodies, Monoclonal -- administration & dosage -- adverse effects -- pharmacokinetics
Antibodies, Monoclonal, Humanized
Biological Availability
Bone Density Conservation Agents -- administration & dosage -- adverse effects -- pharmacokinetics
Bone Neoplasms -- metabolism -- pathology -- secondary -- therapy
Bone Remodeling -- drug effects
Bone and Bones -- drug effects -- metabolism -- pathology
Clinical Trials as Topic
Diphosphonates -- administration & dosage -- adverse effects -- pharmacokinetics
Disease Management
Humans
Imidazoles -- administration & dosage -- adverse effects -- pharmacokinetics
Immunologic Factors -- administration & dosage -- adverse effects -- pharmacokinetics
Neoplasm Metastasis
Neoplasms -- pathology
Outcome Assessment (Health Care)
Palliative Care -- methods
RANK Ligand -- metabolism
Receptor Activator of Nuclear Factor-kappa B -- metabolism
Note générale:Journal Article
Review
SCOPUS: re.j
Langue:Anglais
Identificateurs:urn:issn:1473-7140
info:doi/10.1586/era.11.204
info:scp/84857852442
info:pmid/22192269